{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:15:07Z","timestamp":1773018907344,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbalip.2025.159596","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:11:44Z","timestamp":1737418304000},"page":"159596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dantrolene is an HDL-associated paraoxonase-1 activator with immunosuppressive and atheroprotective properties"],"prefix":"10.1016","volume":"1870","author":[{"given":"Anastasia-Georgia","family":"Dedemadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Sevdali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daphne","family":"Georgiadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftaxia-Konstantina","family":"Valanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elpida","family":"Neofotistou-Themeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Chanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Goutakoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathia","family":"Thymiakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Christopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis","family":"Constantoulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayotis","family":"Verginis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Kardassis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Stratikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2025.159596_bb0005","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2025.159596_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2025.159596_bb0015","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.120.050808","article-title":"High-density lipoprotein anti-inflammatory capacity and incident cardiovascular events","volume":"143","author":"Jia","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2025.159596_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"BBA Clin."},{"key":"10.1016\/j.bbalip.2025.159596_bb0025","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1021\/bi050862i","article-title":"High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I","volume":"44","author":"Gaidukov","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2025.159596_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2025.159596_bb0035","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.3390\/molecules25245980","article-title":"The structure and function of paraoxonase-1 and its comparison to paraoxonase-2 and -3","volume":"25","author":"Taler-Vercic","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbalip.2025.159596_bb0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","article-title":"Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters","volume":"28","author":"Billecke","year":"2000","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.bbalip.2025.159596_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000936","article-title":"Paraoxonase 1: evolution of the enzyme and of its role in protecting against atherosclerosis","volume":"35","author":"Durrington","year":"2024","journal-title":"Curr. \u039fpin. Lipidol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/28406","article-title":"Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis","volume":"394","author":"Shih","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2025.159596_bb0055","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1074\/jbc.M910376199","article-title":"Combined serum paraoxonase knockout\/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159596_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.carpath.2007.10.001","article-title":"Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia","volume":"17","author":"Ng","year":"2008","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0065","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","article-title":"Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome","volume":"26","author":"Mackness","year":"2006","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0070","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/ATVBAHA.112.253930","article-title":"Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk","volume":"32","author":"Tang","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ars.2019.7998","article-title":"Role of paraoxonase1 in the regulation of high-density lipoprotein functionality and in cardiovascular protection","volume":"34","author":"Khalil","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbalip.2025.159596_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1065967","article-title":"Paraoxonase 1 and atherosclerosis","volume":"10","author":"Durrington","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbalip.2025.159596_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005298","article-title":"Effects of paraoxonase 1 gene polymorphisms on heart diseases: systematic review and meta-analysis of 64 case-control studies","volume":"95","author":"Hernandez-Diaz","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbalip.2025.159596_bb0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10528-021-10043-0","article-title":"The role of paraoxonase 1 (PON1) gene polymorphisms in coronary artery disease: a systematic review and meta-analysis","volume":"59","author":"Ashiq","year":"2021","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bbalip.2025.159596_bb0095","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2025.159596_bb0100","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/art.24802","article-title":"Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis","volume":"60","author":"Charles-Schoeman","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2025.159596_bb0105","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/antiox11122317","article-title":"Association between paraoxonase\/arylesterase activity of serum PON-1 enzyme and rheumatoid arthritis: a systematic review and meta-analysis","volume":"11","author":"Erre","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbalip.2025.159596_bb0110","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4238\/vol9-3gmr893","article-title":"The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis","volume":"9","author":"Hashemi","year":"2010","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bbalip.2025.159596_bb0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11033-018-4530-z","article-title":"Association between activity and genotypes of paraoxonase1 L(55)M (rs854560) increases the disease activity of rheumatoid arthritis through oxidative stress","volume":"46","author":"Tanhapour","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbalip.2025.159596_bb0120","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10067-020-05218-w","article-title":"PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients","volume":"40","author":"Zaragoza-Garcia","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.39609","article-title":"Paraoxonase 1 activity is modulated by the rs662 polymorphism and IgG anti-high-density lipoprotein antibodies in patients with rheumatoid arthritis: potential implications for cardiovascular disease","volume":"68","author":"Rodriguez-Carrio","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0130","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1007\/s11033-020-05558-5","article-title":"Carotid plaques in adult rheumatoid arthritis patients; association with paroxonase 1 enzymatic activity and Q192R paroxonase 1 gene polymorphism","volume":"47","author":"Atwa","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbalip.2025.159596_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74016-w","article-title":"Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice","volume":"10","author":"Charles-Schoeman","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2025.159596_bb0140","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","article-title":"Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol","volume":"28","author":"Warnick","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2025.159596_bb0145","article-title":"Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment","author":"Dedemadi","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbalip.2025.159596_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.metabol.2019.06.004","article-title":"Impaired antioxidative activity of high-density lipoprotein is associated with more severe acute ischemic stroke","volume":"98","author":"Tziomalos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2025.159596_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117229","article-title":"HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke and predict its outcome","volume":"540","author":"Papagiannis","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2025.159596_bb0160","article-title":"Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I","volume":"1865","author":"Gkolfinopoulou","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.bbalip.2025.159596_bb0165","first-page":"36","article-title":"Image processing with ImageJ","volume":"11","author":"Abramoff","year":"2004","journal-title":"Biophotonics Int."},{"key":"10.1016\/j.bbalip.2025.159596_bb0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nsmb767","article-title":"Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes","volume":"11","author":"Harel","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0175","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein-protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbalip.2025.159596_bb0180","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2025.159596_bb0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bbalip.2025.159596_bb0190","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0195","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/eji.201646542","article-title":"Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation","volume":"46","author":"Papadaki","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.770820","article-title":"Modulation of ryanodine receptors activity alters the course of experimental autoimmune encephalomyelitis in mice","volume":"12","author":"Osipchuk","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0205","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2025.159596_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JND-150130","article-title":"Long term oral dantrolene improved muscular symptoms in a malignant hyperthermia susceptible individual","volume":"3","author":"Butala","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.bbalip.2025.159596_bb0215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.atherosclerosis.2015.08.028","article-title":"Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice","volume":"243","author":"Tiniakou","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2025.159596_bb0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbrc.2022.07.111","article-title":"Dantrolene, a stabilizer of the ryanodine receptor, prevents collagen-induced arthritis","volume":"624","author":"Nawata","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2025.159596_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxlet.2020.01.017","article-title":"Differences in biological activities between recombinant human paraoxonase 1 (rhPON1) subtype isozemys R\/Q as antidotes against organophosphorus poisonings","volume":"325","author":"Cui","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbalip.2025.159596_bb0230","first-page":"275","article-title":"In silico analysis of the functional and structural impacts of non-synonymous single nucleotide polymorphisms in the human paraxonase 1 gene","volume":"19","author":"Paul","year":"2015","journal-title":"Int. J. Bioautomation"},{"key":"10.1016\/j.bbalip.2025.159596_bb0235","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/01.ATV.17.11.2935","article-title":"Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism","volume":"17","author":"Leviev","year":"1997","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0245","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3390\/antiox9090899","article-title":"Paraoxonase 1 phenotype and protein N-homocysteinylation in patients with rheumatoid arthritis: implications for cardiovascular disease","volume":"9","author":"Parada-Turska","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbalip.2025.159596_bb0250","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s10067-019-04499-0","article-title":"Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis","volume":"38","author":"Bae","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0255","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001588","article-title":"The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis","volume":"4","author":"Liao","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2025.159596_bb0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MOL.0000000000000256","article-title":"High-density lipoprotein function in rheumatoid arthritis","volume":"27","author":"Ormseth","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0265","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/jir.2011.0056","article-title":"Collagen-induced arthritis as an animal model for rheumatoid arthritis: focus on interferon-gamma","volume":"31","author":"Schurgers","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbalip.2025.159596_bb0270","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/art.1780290114","article-title":"Homologous type II collagen induces chronic and progressive arthritis in mice","volume":"29","author":"Holmdahl","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2025.159596_bb0275","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/art.1780340621","article-title":"SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies","volume":"34","author":"Reife","year":"1991","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2025.159596_bb0280","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.3390\/ijms24097764","article-title":"Proteomic exploration of paraoxonase 1 function in health and disease","volume":"24","author":"Jakubowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2025.159596_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110553","article-title":"Paraoxonase-1: how a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancer","volume":"380","author":"Camps","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbalip.2025.159596_bb0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.39833","article-title":"Improvement of high-density lipoprotein function in patients with early rheumatoid arthritis treated with methotrexate monotherapy or combination therapies in a randomized controlled trial","volume":"69","author":"Charles-Schoeman","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2018.04.003","article-title":"Remodeling of the HDL proteome with treatment response to abatacept or adalimumab in the AMPLE trial of patients with rheumatoid arthritis","volume":"275","author":"Charles-Schoeman","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2025.159596_bb0300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1574884711666160915153433","article-title":"Pharmacological interactions of paraoxonase 1 (PON1): a HDL-bound antiatherogenic enzyme","volume":"11","author":"Mahrooz","year":"2016","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.06.002","article-title":"Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression","volume":"48","author":"Martini","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbalip.2025.159596_bb0310","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573409914666180518085908","article-title":"In silico molecular docking and ADME studies of 1,3,4-thiadiazole derivatives in relation to in vitro PON1 activity","volume":"15","author":"Sever","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.bbalip.2025.159596_bb0315","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcb.20064","article-title":"Ryanodine receptor signaling is required for anti-CD3-induced T cell proliferation, interleukin-2 synthesis, and interleukin-2 receptor signaling","volume":"92","author":"Conrad","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2025.159596_bb0320","doi-asserted-by":"crossref","first-page":"37233","DOI":"10.1074\/jbc.M112.398974","article-title":"Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes","volume":"287","author":"Thakur","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2025.159596_bb0325","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.bjp.0701934","article-title":"Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro","volume":"124","author":"Hasko","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0330","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0361-9230(98)00005-7","article-title":"Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-gamma in endotoxemic mice","volume":"46","author":"Nemeth","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbalip.2025.159596_bb0335","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4049\/jimmunol.1201828","article-title":"Paraoxonase-1 suppresses experimental colitis via the inhibition of IFN-gamma production from CD4 T cells","volume":"191","author":"Yamashita","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0340","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene\u2014a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.bbalip.2025.159596_bb0345","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/BOR.0000000000000697","article-title":"Skeletal muscle disease in rheumatoid arthritis: the center of cardiometabolic comorbidities?","volume":"32","author":"Andonian","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbalip.2025.159596_bb0350","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/rheumatology\/ken146","article-title":"Rheumatoid cachexia: a clinical perspective","volume":"47","author":"Summers","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbalip.2025.159596_bb0355","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/rheumatology\/kev412","article-title":"Rheumatoid cachexia: the undiagnosed, untreated key to restoring physical function in rheumatoid arthritis patients?","volume":"55","author":"Lemmey","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbalip.2025.159596_bb0360","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/annrheumdis-2013-205007","article-title":"Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness","volume":"74","author":"Yamada","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbalip.2025.159596_bb0365","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13395-015-0045-7","article-title":"Muscle dysfunction associated with adjuvant-induced arthritis is prevented by antioxidant treatment","volume":"5","author":"Yamada","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.bbalip.2025.159596_bb0370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ebiom.2017.07.023","article-title":"Muscle weakness in rheumatoid arthritis: the role of Ca(2+) and free radical signaling","volume":"23","author":"Yamada","year":"2017","journal-title":"EBioMedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T21:53:30Z","timestamp":1740606810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198125000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1388198125000046"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159596","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dantrolene is an HDL-associated paraoxonase-1 activator with immunosuppressive and atheroprotective properties","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"159596"}}